Year-End Report

THE MCMANUS GROUP for GENENTECH

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Clarification of scope of Mediciad rebates for physician-administered drugs H.R. 2184, "Enhanced Health Care Value for All Act of 2007"

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2184 (110th)

Health Issues HCR

H.R. 1038, "Access to Life-Savings Medicine Act." S. 1695, "Biologics Price Competition and Innovation Act of 2007."

LobbyistCovered position, as disclosed
JOHN MCMANUS N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1695 (110th), H.R. 1038 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.